Human SDC1/CD138/SDC ORF/cDNA clone-Lentivirus particle (NM_001006946)
Cat. No.: vGMLP003528
Pre-made Human SDC1/CD138/SDC Lentiviral expression plasmid for SDC1 lentivirus packaging, SDC1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
CD138/Syndecan-1/SDC1/SDC1/CD138 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP003528 | Human SDC1 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP003528 |
Gene Name | SDC1 |
Accession Number | NM_001006946 |
Gene ID | 6382 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 933 bp |
Gene Alias | CD138,SDC,SYND1,syndecan |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGAGGCGCGCGGCGCTCTGGCTCTGGCTGTGCGCGCTGGCGCTGAGCCTGCAGCCGGCCCTGCCGCAAATTGTGGCTACTAATTTGCCCCCTGAAGATCAAGATGGCTCTGGGGATGACTCTGACAACTTCTCCGGCTCAGGTGCAGGTGCTTTGCAAGATATCACCTTGTCACAGCAGACCCCCTCCACTTGGAAGGACACGCAGCTCCTGACGGCTATTCCCACGTCTCCAGAACCCACCGGCCTGGAGGCTACAGCTGCCTCCACCTCCACCCTGCCGGCTGGAGAGGGGCCCAAGGAGGGAGAGGCTGTAGTCCTGCCAGAAGTGGAGCCTGGCCTCACCGCCCGGGAGCAGGAGGCCACCCCCCGACCCAGGGAGACCACACAGCTCCCGACCACTCATCTGGCCTCAACGACCACAGCCACCACGGCCCAGGAGCCCGCCACCTCCCACCCCCACAGGGACATGCAGCCTGGCCACCATGAGACCTCAACCCCTGCAGGACCCAGCCAAGCTGACCTTCACACTCCCCACACAGAGGATGGAGGTCCTTCTGCCACCGAGAGGGCTGCTGAGGATGGAGCCTCCAGTCAGCTCCCAGCAGCAGAGGGCTCTGGGGAGCAGGACTTCACCTTTGAAACCTCGGGGGAGAATACGGCTGTAGTGGCCGTGGAGCCTGACCGCCGGAACCAGTCCCCAGTGGATCAGGGGGCCACGGGGGCCTCACAGGGCCTCCTGGACAGGAAAGAGGTGCTGGGAGGGGTCATTGCCGGAGGCCTCGTGGGGCTCATCTTTGCTGTGTGCCTGGTGGGTTTCATGCTGTACCGCATGAAGAAGAAGGACGAAGGCAGCTACTCCTTGGAGGAGCCGAAACAAGCCAACGGCGGGGCCTACCAGAAGCCCACCAAACAGGAGGAATTCTATGCCTGA |
ORF Protein Sequence | MRRAALWLWLCALALSLQPALPQIVATNLPPEDQDGSGDDSDNFSGSGAGALQDITLSQQTPSTWKDTQLLTAIPTSPEPTGLEATAASTSTLPAGEGPKEGEAVVLPEVEPGLTAREQEATPRPRETTQLPTTHLASTTTATTAQEPATSHPHRDMQPGHHETSTPAGPSQADLHTPHTEDGGPSATERAAEDGASSQLPAAEGSGEQDFTFETSGENTAVVAVEPDRRNQSPVDQGATGASQGLLDRKEVLGGVIAGGLVGLIFAVCLVGFMLYRMKKKDEGSYSLEEPKQANGGAYQKPTKQEEFYA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Biosimilar | GMP-Bios-INN-865 | Pre-Made Indatuximab Ravtansine Biosimilar, Whole Mab Adc, Anti-Sdc1 Antibody: Anti-CD138/SDC/SYND1/syndecan therapeutic antibody Drug Conjugate |
Biosimilar | GMP-Bios-ab-271 | Pre-Made Indatuximab biosimilar, Whole mAb ADC, Anti-SDC1 Antibody: Anti-SDC/CD138/SYND1/syndecan therapeutic antibody |
Target Antibody | GM-Tg-g-T13017-Ab | Anti-SDC1/ CD138/ SDC monoclonal antibody |
Target Antigen | GM-Tg-g-T13017-Ag | SDC1 VLP (virus-like particle) |
ORF Viral Vector | pGMLP003528 | Human SDC1 Lentivirus plasmid |
ORF Viral Vector | pGMLP004053 | Human SDC1 Lentivirus plasmid |
ORF Viral Vector | vGMLP003528 | Human SDC1 Lentivirus particle |
ORF Viral Vector | vGMLP004053 | Human SDC1 Lentivirus particle |
Target information
Target ID | GM-T13017 |
Target Name | CD138/Syndecan-1/SDC1 |
Gene Group Identifier (Target Gene ID in Homo species) |
6382 |
Gene ID |
100071892 (Equus caballus), 101101459 (Felis catus), 20969 (Mus musculus), 25216 (Rattus norvegicus) 482986 (Canis lupus familiaris), 529759 (Bos taurus), 6382 (Homo sapiens), 701544 (Macaca mulatta) |
Gene Symbols & Synonyms | SDC1,Sdc1,Sstn,Synd,CD138,Synd1,syn-1,HSPG,SYNDECA,Syndecan,SDC,SYND1,syndecan |
Target Alternative Names | CD138, Syndecan-1, SDC1,Syndecan-1,SYND1,SDC,CD138,SYND1,syndecan |
Uniprot Accession |
P18827,P18828,P26260,Q08DZ5
Additional SwissProt Accessions: P18828,P26260,Q08DZ5,P18827 |
Uniprot Entry Name | |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target, INN Index |
Disease | cancer, Ovary Cancer, myeloma patients, Malignant neoplasm of bladder |
Disease from KEGG | ECM-receptor interaction, Cell adhesion molecules, Malaria, Proteoglycans in cancer, Fluid shear stress and atherosclerosis |
Gene Ensembl | ENSECAG00000014709, ENSMUSG00000020592, ENSCAFG00845018675, ENSBTAG00000011154, ENSG00000115884, ENSMMUG00000030922 |
Target Classification | Checkpoint-Immuno Oncology |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.